• 1. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

Market Research and Analysis of 1,5-Dimethyl-1H-pyrazol-3-amine Hydrochloride (1431965-39-7)

1,5-Dimethyl-1H-pyrazol-3-amine hydrochloride, identified by the CAS number 1431965-39-7, is a compound of significant interest in the chemical and pharmaceutical industries. This compound has been studied extensively for its potential applications in drug development, particularly in the fields of oncology and inflammation. Recent research has highlighted its role as a promising lead compound for the design of novel therapeutic agents.

The global market for fine chemicals and intermediates continues to grow, driven by increasing demand from the pharmaceutical and biotechnology sectors. 1,5-Dimethyl-1H-pyrazol-3-amine hydrochloride has emerged as a key intermediate in the synthesis of various bioactive molecules. Its unique chemical properties make it an attractive candidate for use in complex molecular architectures.

Market analysis indicates that the demand for this compound is primarily driven by its application in preclinical studies and early-stage drug development. Key regions exhibiting high demand include North America, Europe, and Asia-Pacific, with China and India emerging as significant markets due to their rapidly expanding pharmaceutical industries.

Suppliers of 1,5-Dimethyl-1H-pyrazol-3-amine hydrochloride are increasingly focusing on improving production efficiency and ensuring compliance with stringent regulatory standards. The competitive landscape is characterized by a mix of multinational corporations and specialized fine chemical manufacturers.

In conclusion, 1,5-Dimethyl-1H-pyrazol-3-amine hydrochloride represents a valuable asset in the chemical toolbox for drug discovery. As research progresses and new applications are identified, its market presence is expected to grow further, solidifying its role as an essential intermediate in the development of innovative therapeutic solutions.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)